OCT 10, 2018 1:30 PM PDT

Discovery of Biomarkers Predictive of Anticancer Drug Response in Preclinical Settings

Speaker

Abstract

One of the main challenges in precision medicine consists of developing predictors of drug response to select the most beneficial therapy for each individual patient. In this context, preclinical models are crucial to study the association between molecular features of tumor cells and response to chemical perturbations. However, only few predictors have been successfully translated to clinical settings. Such a low success rate is due not only to the complexity of the mechanisms underlying anticancer drug response, but also to the lack of robustness of the predictors developed in preclinical settings. To address this issue we developed PharmacoGx, a computational platform enabling meta-analysis of large-scale drug screenings of in vitro and in vivo model systems, and PharmacoDB (pharmacodb.pmgenomics.ca), a web-application enabling quick access to a large compendium of pharmacogenomics datasets. In this presentation I will show how we used our new platforms to (i) identify pathways whose genomic and transcriptomic patterns are preserved between model systems and patient tumors, and (ii) develop univariate and multivariate predictors of drug response that can be validated in clinical trial data. 

Learning Objectives: 

1. Learn about the potential and limitations of biomarker discovery using preclinical pharmacogenomic data
2. Learn about the computational tools available for biomarker discovery in preclinical settings


Show Resources
You May Also Like
JUN 28, 2022 6:45 AM PDT
JUN 28, 2022 6:45 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUL 19, 2022 8:00 AM PDT
JUL 19, 2022 8:00 AM PDT
Date: July 19, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Traditional liver perfusion procedures are difficult to perform and require extensive training, steady hands, and long-st...
APR 26, 2022 7:00 AM PDT
C.E. CREDITS
APR 26, 2022 7:00 AM PDT
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
OCT 10, 2018 1:30 PM PDT

Discovery of Biomarkers Predictive of Anticancer Drug Response in Preclinical Settings



Show Resources
Loading Comments...
Show Resources